Osaic Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
3,340
+69
| +2% | +$4.27K | ﹤0.01% | 3577 |
|
|
2025
Q1 | $231K | Sell |
3,271
-1,175
| -26% | -$83.1K | ﹤0.01% | 3509 |
|
|
2024
Q4 | $210K | Buy |
4,446
+981
| +28% | +$46.4K | ﹤0.01% | 3552 |
|
|
2024
Q3 | $244K | Sell |
3,465
-1,215
| -26% | -$85.4K | ﹤0.01% | 3495 |
|
|
2024
Q2 | $385K | Sell |
4,680
-1,834
| -28% | -$151K | ﹤0.01% | 2983 |
|
|
2024
Q1 | $569K | Sell |
6,514
-13,597
| -68% | -$1.19M | ﹤0.01% | 2833 |
|
|
2023
Q4 | $1.94M | Sell |
20,111
-3,481
| -15% | -$336K | ﹤0.01% | 1885 |
|
|
2023
Q3 | $2.09M | Buy |
23,592
+8,077
| +52% | +$715K | ﹤0.01% | 1952 |
|
|
2023
Q2 | $1.34M | Sell |
15,515
-2,615
| -14% | -$226K | ﹤0.01% | 2215 |
|
|
2023
Q1 | $1.76M | Buy |
18,130
+784
| +5% | +$76.3K | ﹤0.01% | 1928 |
|
|
2022
Q4 | $1.8M | Sell |
17,346
-177
| -1% | -$18.3K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $1.49M | Sell |
17,523
-237
| -1% | -$20.1K | ﹤0.01% | 1865 |
|
|
2022
Q2 | $1.47M | Sell |
17,760
-3,827
| -18% | -$317K | ﹤0.01% | 1911 |
|
|
2022
Q1 | $1.64M | Sell |
21,587
-2,208
| -9% | -$168K | ﹤0.01% | 2104 |
|
|
2021
Q4 | $2.1M | Buy |
23,795
+46
| +0.2% | +$4.07K | ﹤0.01% | 1739 |
|
|
2021
Q3 | $1.84M | Buy |
23,749
+342
| +1% | +$26.4K | ﹤0.01% | 1781 |
|
|
2021
Q2 | $1.95M | Buy |
23,407
+1,126
| +5% | +$94K | ﹤0.01% | 1747 |
|
|
2021
Q1 | $1.67M | Buy |
22,281
+3,325
| +18% | +$250K | ﹤0.01% | 1762 |
|
|
2020
Q4 | $1.66M | Buy |
18,956
+2,645
| +16% | +$232K | ﹤0.01% | 1597 |
|
|
2020
Q3 | $1.25M | Sell |
16,311
-2,988
| -15% | -$230K | ﹤0.01% | 1655 |
|
|
2020
Q2 | $2.38M | Buy |
19,299
+3,937
| +26% | +$485K | 0.01% | 1153 |
|
|
2020
Q1 | $1.3M | Buy |
+15,362
| New | +$1.3M | 0.01% | 1334 |
|